302 related articles for article (PubMed ID: 25424672)
1. [Assessment of an active pharmacovigilance system carried out by a pharmacist].
Sánchez I; Amador C; Plaza JC; Correa G; Amador R
Rev Med Chil; 2014 Aug; 142(8):998-1005. PubMed ID: 25424672
[TBL] [Abstract][Full Text] [Related]
2. A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal.
Marques J; Ribeiro-Vaz I; Pereira AC; Polónia J
Int J Pharm Pract; 2014 Aug; 22(4):275-82. PubMed ID: 24188533
[TBL] [Abstract][Full Text] [Related]
3. Targeted therapies and adverse drug reactions in oncology: the role of clinical pharmacist in pharmacovigilance.
Fornasier G; Taborelli M; Francescon S; Polesel J; Aliberti M; De Paoli P; Baldo P
Int J Clin Pharm; 2018 Aug; 40(4):795-802. PubMed ID: 29785683
[TBL] [Abstract][Full Text] [Related]
4. Adverse drug reactions' reporting in a Mexican hospital.
Valdez-Ramírez LA; Serrano-Medina A; Cornejo-Bravo JM
Int J Pharm Pract; 2020 Dec; 28(6):660-662. PubMed ID: 32476179
[TBL] [Abstract][Full Text] [Related]
5. A comprehensive intervention for adverse drug reactions identification and reporting in a Pediatric Emergency Department.
Morales Ríos O; Jasso Gutiérrez L; Talavera JO; Téllez-Rojo MM; Olivar López V; Garduño Espinosa J; Muñoz Hernández O
Int J Clin Pharm; 2016 Feb; 38(1):80-7. PubMed ID: 26499501
[TBL] [Abstract][Full Text] [Related]
6. Online reporting of adverse drug reactions: a study from a French regional pharmacovigilance center.
Abadie D; Chebane L; Bert M; Durrieu G; Montastruc JL
Therapie; 2014; 69(5):395-400. PubMed ID: 25269141
[TBL] [Abstract][Full Text] [Related]
7. Does spontaneous adverse drug reactions' reporting differ between different reporters? A study in Toulouse Pharmacovigilance Centre.
Nicol C; Moulis F; Bondon-Guitton E; Durrieu G; Montastruc JL; Bagheri H
Therapie; 2019 Oct; 74(5):521-525. PubMed ID: 31029402
[TBL] [Abstract][Full Text] [Related]
8. Adverse drug reactions experience in a teaching hospital in Jordan.
Alsbou M; Alzubiedi S; Alzobi H; Samhadanah NA; Alsaraireh Y; Alrawashdeh O; Aqel A; Al-Salem K
Int J Clin Pharm; 2015 Dec; 37(6):1188-93. PubMed ID: 26286340
[TBL] [Abstract][Full Text] [Related]
9. Patterns of adverse drug reaction signals in NAFDAC pharmacovigilance activities from January to June 2015: safety of drug use in Nigeria.
Awodele O; Aliu R; Ali I; Oni Y; Adeyeye CM
Pharmacol Res Perspect; 2018 Oct; 6(5):e00427. PubMed ID: 30324768
[TBL] [Abstract][Full Text] [Related]
10. Adverse drug reactions in elderly: a five-year review of spontaneous reports to the Portuguese pharmacovigilance system.
Monteiro C; Duarte AP; Alves G
Expert Opin Drug Saf; 2021 Jan; 20(1):109-118. PubMed ID: 33170742
[No Abstract] [Full Text] [Related]
11. Adverse drug reactions reported to a provincial public health sector pharmacovigilance programme in South Africa.
Jones J; Swart A; Tommy E; Cohen K; Stewart A; Voget J; Blockman M
S Afr Med J; 2020 Nov; 110(12):1226-1230. PubMed ID: 33403970
[TBL] [Abstract][Full Text] [Related]
12. The importance of monitoring adverse drug reactions in elderly patients: the results of a long-term pharmacovigilance programme.
Carnovale C; Gentili M; Fortino I; Merlino L; Clementi E; Radice S; ViGer Group
Expert Opin Drug Saf; 2016; 15(2):131-9. PubMed ID: 26882049
[TBL] [Abstract][Full Text] [Related]
13. Impact of a pharmacist-driven pharmacovigilance system in a secondary hospital in the Gauteng Province of South Africa.
Terblanche A; Meyer JC; Godman B; Summers RS
Hosp Pract (1995); 2018 Oct; 46(4):221-228. PubMed ID: 30092683
[TBL] [Abstract][Full Text] [Related]
14. Patterns of Adverse Drug Reactions in Different Age Groups: Analysis of Spontaneous Reports by Community Pharmacists.
Yu YM; Shin WG; Lee JY; Choi SA; Jo YH; Youn SJ; Lee MS; Choi KH
PLoS One; 2015; 10(7):e0132916. PubMed ID: 26172050
[TBL] [Abstract][Full Text] [Related]
15. Characterization of Severe Adverse Drug Reactions at a Free-Standing Children's Hospital.
Yu D; Sheets J; Suppes S; Goldman J
J Clin Pharmacol; 2019 Dec; 59(12):1569-1572. PubMed ID: 31309572
[TBL] [Abstract][Full Text] [Related]
16. Effect of pharmacist involvement on patient reporting of adverse drug reactions: first Italian study.
Leone R; Moretti U; D'Incau P; Conforti A; Magro L; Lora R; Velo G
Drug Saf; 2013 Apr; 36(4):267-76. PubMed ID: 23475583
[TBL] [Abstract][Full Text] [Related]
17. Adverse drug reactions in Nigerian children: a retrospective review of reports submitted to the Nigerian Pharmacovigilance Centre from 2005 to 2012.
Obebi Cliff-Eribo K; Sammons H; Star K; Ralph Edwards I; Osakwe A; Choonara I
Paediatr Int Child Health; 2016 Nov; 36(4):300-304. PubMed ID: 26384567
[TBL] [Abstract][Full Text] [Related]
18. Pharmacovigilance implemented by patients: A necessity in the 21st century.
Lafond J
Therapie; 2016 Apr; 71(2):245-7. PubMed ID: 27080846
[TBL] [Abstract][Full Text] [Related]
19. [Adverse drug reactions and prescription errors: morbi-mortality].
Chaio S; Toibaro J; Valicenti P; Saidón P
Medicina (B Aires); 2013; 73(2):111-8. PubMed ID: 23570758
[TBL] [Abstract][Full Text] [Related]
20. Adverse drug reaction monitoring in a secondary care hospital in South India.
Arulmani R; Rajendran SD; Suresh B
Br J Clin Pharmacol; 2008 Feb; 65(2):210-6. PubMed ID: 17662089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
